ES8401722A1 - Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b. - Google Patents

Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.

Info

Publication number
ES8401722A1
ES8401722A1 ES517524A ES517524A ES8401722A1 ES 8401722 A1 ES8401722 A1 ES 8401722A1 ES 517524 A ES517524 A ES 517524A ES 517524 A ES517524 A ES 517524A ES 8401722 A1 ES8401722 A1 ES 8401722A1
Authority
ES
Spain
Prior art keywords
influenzae type
combined vaccine
outer membrane
membrane component
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517524A
Other languages
English (en)
Other versions
ES517524A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES517524A0 publication Critical patent/ES517524A0/es
Publication of ES8401722A1 publication Critical patent/ES8401722A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE VACUNAS CONTRA EL PATOGENO H INFLUENZAE TIPO B.CONSISTE EN COMBINAR EL POLISACARIDO CAPSULAR DE FOSFATO DE POLIRIBOSIL RIBITOL FPR, AISLADO Y PURIFICADO A PARTIR DE HAEMOPHILUS INFLUENZAE TIPO B, CON ANTIGENOS AISLADOS Y PURIFICADOS A PARTIR DE UN COMPONENTE DE MEMBRANA EXTERIOR DE BORDETELLA PERTUSSIS. EL METODO DE OBTENCION DEL FPR PUEDE SER A PARTIR DE LA CEPA H INFLUENZAE TIPO B O A PARTIR DE LA CEPA CK DE H INFLUENZAE TIPO B.TIENE APLICACION POR INDUCIR INMUNIZACION ACTIVA EN ANIMALES DE SANGRE CALIENTE.
ES517524A 1981-11-19 1982-11-19 Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b. Expired ES8401722A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/323,523 US4474758A (en) 1981-11-19 1981-11-19 Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Publications (2)

Publication Number Publication Date
ES517524A0 ES517524A0 (es) 1984-01-01
ES8401722A1 true ES8401722A1 (es) 1984-01-01

Family

ID=23259565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517524A Expired ES8401722A1 (es) 1981-11-19 1982-11-19 Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.

Country Status (13)

Country Link
US (1) US4474758A (es)
EP (1) EP0080021B1 (es)
JP (1) JPS5892618A (es)
AR (1) AR229929A1 (es)
AU (1) AU554028B2 (es)
CA (1) CA1192840A (es)
DE (1) DE3269381D1 (es)
DK (1) DK514882A (es)
ES (1) ES8401722A1 (es)
MX (1) MX7197E (es)
NZ (1) NZ202483A (es)
PH (1) PH18773A (es)
ZA (1) ZA828517B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5300632A (en) * 1986-11-18 1994-04-05 Research Foundation Of State University Of New York Method for purifying an outer membrane protein of Haemophilus influenzae
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5045456A (en) * 1989-06-12 1991-09-03 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5039610A (en) * 1989-06-12 1991-08-13 Merck & Co., Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
US5019502A (en) * 1989-06-12 1991-05-28 Merck & Company, Inc. Process for removing bacterial endotoxin from gram-negative polysaccharides
IL98715A0 (en) * 1990-08-13 1992-07-15 American Cyanamid Co Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
EP0471954A3 (en) * 1990-08-13 1993-03-03 American Cyanamid Company Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
US7704959B2 (en) 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing antibodies in cilus pertussis
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Also Published As

Publication number Publication date
NZ202483A (en) 1986-03-14
ES517524A0 (es) 1984-01-01
CA1192840A (en) 1985-09-03
ZA828517B (en) 1983-09-28
DE3269381D1 (en) 1986-04-03
AU9071482A (en) 1983-05-26
US4474758A (en) 1984-10-02
PH18773A (en) 1985-09-25
MX7197E (es) 1987-12-23
AR229929A1 (es) 1984-01-31
JPS5892618A (ja) 1983-06-02
DK514882A (da) 1983-05-20
EP0080021A3 (en) 1983-11-16
EP0080021B1 (en) 1986-02-26
EP0080021A2 (en) 1983-06-01
AU554028B2 (en) 1986-08-07

Similar Documents

Publication Publication Date Title
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
NO913812L (no) Oligosakkaridkonjugatvaksiner.
DE69409962T2 (de) Immuntoleranzinduzierendes agens
KR920002790A (ko) 보르데텔라 퍼투스시스에 의해 발병되는 질병을 예방하는데 유효한 백신 및 비백일해 백신 성분과 조합된 상기 백신으로 구성되는 다가성 백신
ES8401722A1 (es) Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b.
EP0024493A3 (en) Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
EA199700419A1 (ru) Вакцинная композиция, содержащая полирибозилрибитолфосфат, и способ ее получения
NO174630C (no) Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner
EP0306524A4 (en) ANTI-DETERMINANTS DETECTED BY ANTIBODIES PRODUCED BY USING A RESTRICTED NUMBER OF ANTIGENT PRESENTING PATHOGENIC AGENTS OR DERIVATIVES.
NZ223009A (en) Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
NZ309713A (en) Oligosaccharides of S pneumoniae serotype 8 and their use in a vaccine
ES8608883A1 (es) Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular.
EP0302887A4 (en) ANTIGENS, ANTIBODIES, BACTERIAL VACCINES AND THEIR PRODUCTION METHOD.
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
UA27754C2 (uk) Комбінована педіатрична вакцина, спосіб одночасної комбінованої вакцинації
ES8502339A1 (es) Procedimiento de obtencion de una vacuna para ejercer la formacion de anticuerpo de fosfato de poliribosilribitol (prp) en un animal de sangre caliente
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
AU7547987A (en) Method of preparation and use for feline leukemia virus antigens
IL55433A (en) Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens
ES8301635A1 (es) Procedimiento de obtencion de una composicion de vacuna para la inmunizacion de ovejas contra el aborto enzootico.
NL194960B (nl) Werkwijze voor het bereiden van mutantstammen van Bordetella bronchiseptica en daarop gebaseerd levend verzwakt vaccin.
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens